Egypt Diabetes Devices Market Size, Share, Growth, Trends, and Industry Analysis: By Product Type, By Device Type, By Delivery Type, By Distribution Channel and Country

Egypt Diabetes Devices Market Size, Share, Growth, Trends, and Industry Analysis: By Product Type (Blood Glucose Monitoring Devices, Insulin Delivery Devices, Artificial Pancreas Systems), By Device Type (Self-Monitoring, Diagnostic Devices), By Delivery Type (Pumps, Insulin Pens, Syringes, Injectors, Disposable Pen, Jet Injectors), By Distribution Channel (Hospitals, Clinics, Retail Sales, Online Pharmacies) and Country

Egypt Diabetes Devices Market size was valued at US$ 423.9 million in 2023 and is projected to reach a value of US$ 550.4 million by 2030, growing at a CAGR of 3.8% from 2024-2030.

The Egypt Diabetes Devices market is the market for medical devices used to treat and manage diabetes. Diabetes devices refer to various medical technologies designed to help individuals manage their diabetes effectively, these devices assist patients in monitoring their blood sugar levels and administering insulin without needing manual injections, making diabetes management easier and less invasive. the key drivers of the market are increasing prevalence of diabetes, rising awareness of diabetes treatment and management. However, the key restraints of the market are high cost of devices, lack of awareness about diabetes management and the benefits of using advanced devices. Additionally, the opportunities of the market are innovations in diabetes care, such as continuous glucose monitoring systems (CGMS) and smart insulin pens offer more efficient and user-friendly solutions, integration with digital health. The key trends of the market are increased adoption of insulin delivery devices, increased focus on paediatric diabetes management, rising demand for compact and portable devices.

Key Players

The leading companies highlighted in the market report include such as such as Abbott Diabetes Care, Medtronic PLC, Roche Diabetes Care, Eli Lilly and Company, Novo Nordisk A/S, Sanofi S.A, Omnipod, and others. Also, a comprehensive analysis of industry verticals and market participants that provides a clear overview of the competitive landscape in relation to the sectors served by the company’s products and services, market share, service offerings, financial reports, significant developments, market strategy, competitive position, and geographic reach.

Key Takeaways

  • The growth rate of the market was estimated to grow at a compound annual growth rate (CAGR) of approximately 7.45% from 2024 to 2030.
  • Based on product type, the blood glucose monitoring devices segment is dominant in 2023.
  • Based on device type, the self-monitoring device segment is dominating the market.
  • Based on delivery type, the insulin pens has captured the highest market share in 2023.   
  • Based on distribution channel, the retain sales has expected to dominate the market in coming forecast years.

Facts & Figures

  • In 2019, Abbott and Dexcom have introduced advanced continuous glucose monitoring devices, such as the Freestyle Libre and Dexcom G6, into the Egyptian market. These devices have gained popularity due to their ease of use and ability to provide real-time glucose monitoring without the need for frequent finger-pricking.
  • In 2021, Novo Nordisk partnered with the Ministry of Health and Population in Egypt to improve diabetes care, focusing on early detection, patient education, and the adoption of advanced diabetes devices. Such collaborations have accelerated the deployment of innovative products and improved access to diabetes management tools.

Key Developments

In May 2021, Medtronic plc introduced that the corporation had acknowledged European adoption for 2 diabetes management devices, first in pen, an associated insulin pen aimed at customers demanding day-to-day injections. The second is Guardian 4 sensor, planned to be used either as a standalone constant glucose monitor or within a pen, and together are CE noticeable.

Egypt Diabetes Devices Market Segmentation

By Product Type: Among the all the product types, the blood glucose monitoring devices is dominating the market. This dominance is driven by the increasing prevalence of diabetes worldwide and the critical need for regular blood glucose monitoring to manage the condition effectively. Continuous glucose monitoring (CGM) systems and self-monitoring blood glucose (SMBG) devices are particularly popular, as they provide real-time data and help patients maintain better control over their blood sugar levels.

By Device Type: The self-monitoring segment is most widely used in the market as it allows individuals to easily and frequently monitor their blood glucose levels at home. Self-monitoring blood glucose (SMBG) devices, such as glucometers and test strips, provide real-time data that helps patients manage their diabetes more effectively. This segment is particularly popular among people with type 2 diabetes, who need to regularly check their blood sugar levels to adjust their diet, exercise, and medication.

By Delivery Type: Among all the delivery types, insulin pens are dominating the market due to several factors like they are more convenient and easier to use compared to traditional syringes and vials, they are compact and portable allowing patients to administer insulin discreetly and on the go. These are the factors which are driving the growth of market. 

Egypt Diabetes Devices Market Dynamics

Drivers

Rising awareness of diabetes treatment and management is a key driver of the market as it leads to greater demand for effective monitoring and management tools. As people become more knowledgeable about the importance of regular glucose monitoring, insulin management, and maintaining healthy lifestyles, they are more likely to adopt advanced diabetes devices. This awareness is driven by public health campaigns, education initiatives, and the increasing availability of information about diabetes care.

Restraints

The high cost of diabetes devices is a key restraint of the market as it can limit accessibility for many patients. Advanced devices like continuous glucose monitors (CGMs) and insulin pumps are often expensive. These high costs can result in significant out-of-pocket expenses for patients, leading to financial burden and potential rationing of essential supplies. This financial barrier can slow down the adoption of advanced diabetes management technologies, particularly in lower-income populations and emerging markets.

Opportunites

Integration with digital health represents a key opportunity for the market because it enhances patient engagement, monitoring, and overall disease management. By connecting diabetes devices like continuous glucose monitors (CGMs) and insulin pumps with mobile apps and telehealth services, patients can access real-time data on their blood sugar levels, track their medication usage, and receive personalized feedback and recommendations.

Trends

The rising demand for compact and portable diabetes devices is a key trend in the market because it aligns with the need for convenience and mobility in diabetes management. Patients prefer devices that are easy to carry and use, allowing them to monitor their blood glucose levels and administer insulin on the go. This trend is driving innovation in the development of smaller, more user-friendly devices such as wearable continuous glucose monitors (CGMs) and portable insulin pens. These compact devices improve patient compliance and quality of life by making diabetes management more accessible and less intrusive.

Egypt Diabetes Devices Market Segmentation Analysis

Report Benchmarks

Details

Market Size in 2023

US$ 423.9 million

Market Size in 2030

US$ 550.4 million

By Product Type

  • Blood Glucose Monitoring Devices
  • Insulin Delivery Devices
  • Artificial Pancreas Systems

By Device Type

  • Self-Monitoring
  • Diagnostic Devices

By Delivery Type

  • Pumps
  • Insulin Pens
  • Syringes
  • Injectors
  • Disposable Pen
  • Jet Injectors

By Distribution Channel

  • Hospitals
  • Clinics
  • Retail Sales
  • Online Pharmacies

Analyst Review

The market is experiencing growth driven by the increasing prevalence of diabetes and the need for effective blood glucose management. The market is seeing a rise in the adoption of various diabetes care devices, including self-monitoring blood glucose devices (glucometers, test strips, and lancets) and continuous glucose monitoring devices (sensors and durables). Additionally, the demand for insulin pens and insulin pumps is increasing as patients seek more convenient and accurate methods for insulin delivery. These devices are becoming more popular due to their ease of use and portability, making diabetes management more accessible for patients. Overall, the market is poised for continued expansion as it addresses the growing healthcare needs of the population and embraces technological advancements in diabetes care.

Key Features of the Report

  • The egypt diabetes devices market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies.
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market.
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market.
  • The report provides a plethora of information about Market entry strategies, regulatory framework, and reimbursement scenarios.
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis in addition to recent technology advancements and innovations in the market

Download Free Sample Report

Frequently Asked Questions

Egypt diabetes devices market size was valued at US$ 423.9 million in 2023 and is set to reach a value of US$ 550.4 million by 2030, at a CAGR of 3.8%

• Increased adoption of insulin delivery devices
• Increased focus on paediatric diabetes management, rising demand for compact and portable devices.

Blood glucose monitoring have captured highest market share in the market.

Insulin delivery type is most effective in the market.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2. Egypt Diabetes Devices Market Introduction 
2.1. Egypt Diabetes Devices Market - Taxonomy
2.2. Egypt Diabetes Devices Market - Definitions
2.2.1.Product Type
2.2.2.Device Type
2.2.3.Delivery Type
2.2.4.Distribution Channel
3. Egypt Diabetes Devices Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Egypt Diabetes Devices Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Egypt Diabetes Devices Market By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Blood Glucose Monitoring Devices
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Insulin Delivery Devices
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Artificial Pancreas Systems
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6. Egypt Diabetes Devices Market By Device Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Self-Monitoring
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Diagnostic Devices
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
7. Egypt Diabetes Devices Market By Delivery Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Pumps
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Insulin Pens
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Syringes
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Injectors
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Disposable Pen
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
7.6. Jet Injectors
7.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.6.3. Market Opportunity Analysis 
8. Egypt Diabetes Devices Market By Distribution Channel, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Hospitals
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Clinics
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Retail Sales
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Online Pharmacies
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
9. Competition Landscape
9.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
9.2.1.Abbott Diabetes Care
9.2.2.Medtronic PLC
9.2.3.Roche Diabetes Care
9.2.4.Eli Lilly and Company
9.2.5.Novo Nordisk A/S
9.2.6.Sanofi S.A
9.2.7.Omnipod
10. Research Methodology 
11. Appendix and Abbreviations 

Key Market Players

  • Abbott Diabetes Care
  • Medtronic PLC
  • Roche Diabetes Care
  • Eli Lilly and Company
  • Novo Nordisk A/S
  • Sanofi S.A
  • Omnipod

Related Industry Reports